vitiligo
Conditions
Interventions
control group:0.1% tacrolimus ointment, once per day
308nm excimer laser, twice per week
0.9% sodium chloride injection was intraperitoneally injected, once /3 weeks
The experimental group 1:0.1% tacrolimus ointment, once per day
Intradermal injection of fructus psoraleae injection, 1 time /3 weeks
The experimental group 2:0.1% tacrolimus ointment, once per day
Intraperitoneal injection of autologous PRP combined with psoralba injection was performed once /2 weeks.
The experimental group 3:0.1% tacrolimus ointment, once per day
Intraperitoneal injection of autologous PRP lesions, 1 time /3 weeks
Sponsors
Beijing Friendship Hospital affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
8 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosis of vitiligo patients; 2. Aged 18-65 years, male or female; 3. Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: Women during pregnancy or lactation; Patients who received ultraviolet treatment within 6 months; Patients treated with photosensitive drugs; Patients who have received systematic medication in the past 1 month;Cataract and diabetes; Patients with abnormal liver and kidney function; Treatment of allergic patients with psoralba and ultraviolet radiation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area of leukoplakia; | — |
Countries
China
Contacts
Public ContactYang Gaoyun
Beijing Friendship Hospital Affiliated to Capital Medical University
Outcome results
None listed